S100A8 and gastric cancer: In our study, we verified the oncogenic role of miR-223-3p in gastric cancer, which is consistent with the results from Ma et al.33 Importantly, we found that the miR-223-3p inhibitor reversed CagA-mediated promotion of cell proliferation and migration.